| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $5.4B | $5.0B | $4.4B | $1.7B | $0.1B |
| Cost of Revenue | $5.2B | $6.2B | $6.5B | $4.8B | $0.5B |
| Gross Profit | $0.1B | $-1.2B | $-2.0B | $-3.1B | $-0.5B |
| R&D Expense | $1.7B | $1.6B | $2.0B | $1.9B | $1.9B |
| SG&A Expense | $2.1B | $1.9B | $1.7B | $1.8B | $1.2B |
| Operating Income | $-3.6B | $-4.7B | $-5.7B | $-6.9B | $-4.2B |
| Net Income | $-3.6B | $-4.7B | $-5.4B | $-6.8B | $-4.7B |
| EPS (Basic) | $-3.07 | $-4.69 | $-5.74 | $-7.40 | $-22.98 |
| EPS (Diluted) | $-3.07 | $-4.69 | $-5.74 | $-7.40 | $-22.98 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $14.9B | $15.4B | $16.8B | $17.9B | $22.3B |
| Current Assets | $8.6B | $10.6B | $12.3B | $13.1B | $18.6B |
| Cash & Equivalents | $3.6B | $5.3B | $7.9B | $11.6B | $18.1B |
| Total Liabilities | $10.3B | $8.8B | $7.6B | $4.1B | $2.8B |
| Current Liabilities | $3.7B | $2.3B | $2.5B | $2.4B | $1.3B |
| Stockholders' Equity | — | — | $9.1B | $13.8B | $19.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $-0.8B | $-1.7B | $-4.9B | $-5.1B | $-2.6B |
| Investing Cash Flow | $-1.8B | $-2.0B | $-2.5B | $-1.4B | $-1.8B |
| Capital Expenditures | $1.7B | $1.1B | $1.0B | $1.4B | $1.8B |
| Financing Cash Flow | $0.9B | $1.1B | $3.1B | $0.1B | $19.8B |